story of the week
Ulcerative Colitis: Supplemental Bifid Triple Viable Capsule Treatment Improves Inflammatory Response
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMC Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Supplemental bifid triple viable capsule treatment improves inflammatory response and T cell frequency in ulcerative colitis patients
BMC Gastroenterol 2021 Aug 04;[EPub Ahead of Print], S Li, Y Yin, D Xiao, Y ZouFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.